Suchergebnisse - "Perez-Quilis, Carme"

PubPharm (46)

1

Being fit in the COVID-19 era and future epidemics prevention : Importance of cardiopulmonary exercise test in fitness evaluation

enthalten in: Progress in cardiovascular diseases | 2024

von de la Guía-Galipienso, F. | Palau, P. | Berenguel-Senen, A. | +9

2

Exercise effects on cardiovascular disease : from basic aspects to clinical evidence

enthalten in: Cardiovascular research | 2022

von Sanchis-Gomar, F. | Lavie, C. | Marín, J. | +5

3

In reply- Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19

enthalten in: Mayo Clinic proceedings | 2020

von Sanchis-Gomar, F. | Lavie, C. | Perez-Quilis, C. | +2

CommentOn: Mayo Clin Proc. 2020 Jun;95(6):1222-1230. - PMID 32376099

4

Amiodarone in the COVID-19 Era : Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?

enthalten in: American journal of cardiovascular drugs : drugs, devices, and other interventions | 2020

von Sanchis-Gomar, F. | Lavie, C. | Morin, D. | +3

5

Statins and other drugs : Facing COVID-19 as a vascular disease

enthalten in: Pharmacological research | 2020

von Sanchis-Gomar, F. | Perez-Quilis, C. | Favaloro, E. | +1

CommentOn: J Am Med Dir Assoc. 2020 Jul;21(7):909-914.e2. - PMID 32674818

6

Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?

enthalten in: American journal of cardiovascular drugs | 2020

von Sanchis-Gomar, F. | Lavie, C. | Morin, D. | +3

7

Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?

enthalten in: American journal of cardiovascular drugs | 2020

von Sanchis-Gomar, F. | Lavie, C. | Morin, D. | +3

8

Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?

enthalten in: American journal of cardiovascular drugs | 2020

von Sanchis-Gomar, F. | Lavie, C. | Morin, D. | +3

9

In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation : In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

enthalten in: Mayo Clinic proceedings | 2020

von Sanchis-Gomar, F. | Lavie, C. | Perez-Quilis, C. | +2

CommentOn: Mayo Clin Proc. 2020 Jun;95(6):1222-1230. - PMID 32376099

10

Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?

enthalten in: European heart journal | 2020

von Sanchis-Gomar, F. | Perez-Quilis, C. | Lavie, C.

CommentOn: Eur Heart J. 2020 May 14;41(19):1821-1829. - PMID 32383763

1
2
3
4
5
Nächster »
[5]